Emery Pharma

Investorcompany

Member since March 2026

—

Volume

—

Sold

—

Financed

—

Closed

—

Area

AI SummaryBeta

Emery Pharma is an investor company that focuses on innovative healthcare solutions. Recently, they led a $37 million investment in Centivax for the development of a universal flu vaccine.

AI-generated from Traded deal data. May contain errors.

No bio available yet

This broker hasn't added a bio to their profile yet. Check back later for more details about their background and expertise.

Top Deals

SOLD

Share this deal

Open in a new tab

Centivax Secures $37 Million Investment Led By Structure Fund For Universal Flu Vaccine Development

+ 1

Markets

Member since: March 2026

Deals

SOLD

Centivax Secures $37 Million Investment Led By Structure Fund For Universal Flu Vaccine Development

CRE

Mar 30, 2026